MVP
MEDICALDEV FPO [MVP]
Healthcare · ASX Small Cap
$0.4400 -1.1%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 3 consecutive scans→ Score -6First seen: 2026-02-25
Score Breakdown
Technical53
Catalyst50
Sentiment50
Fundamental89
Momentum44
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- Bollinger squeeze (breakout building)
- Volatility contracting (breakout setup)
- Cash positive / operating cashflow positive
- 4C filed 2026-01-29
- Low P/S ratio (1.2x)
- Moderate revenue growth (+8%)
- Near 52-week low (7% of range)
- Small-cap ($20-100M)
- CANSLIM A: Turned profitable
- CANSLIM I: Institutional ownership (25%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Negative profit margins (-1%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-22%)
Recent Catalysts
NONE FY26 Half Year Announcement
NONE FY26 Half Year Presentation
NONE FY26 Half Year Report (including Appendix 4D)
LOW Appendix 4C and Quarterly Activity Report 31 December 2025
Recent ASX Announcements
| 2026-02-18 | FY26 Half Year Announcement PRICE SENSITIVE |
| 2026-02-18 | FY26 Half Year Presentation PRICE SENSITIVE |
| 2026-02-18 | FY26 Half Year Report (including Appendix 4D) PRICE SENSITIVE |
| 2026-02-16 | FY26 Half Year Announcement Details |
| 2026-01-29 | Appendix 4C and Quarterly Activity Report 31 December 2025 PRICE SENSITIVE |
Key Metrics
$50.1M
Market Cap
104K
Avg Volume
1.1x
Vol Ratio
$0.42 — $0.77
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-0.8%
ROE
-1.1%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | improving | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 68% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | pass | Inst: 25% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #60 of 119 · Sector avg: 51
View all Healthcare signals →